Larimar Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Larimar Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Larimar Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 63.8M shares, a 45.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 63.8M +19.9M +45.3% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 63.8M +20.5M +47.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 63.8M +20.5M +47.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.9M +640K +1.48% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 43.9M +637K +1.47% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 43.3M +25.6M +144% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 43.3M +25.6M +144% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 43.3M +25.6M +144% Dec 31, 2022 10-K 2024-03-14
Q3 2022 43.3M +25.6M +144% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 17.7M +2.34M +15.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 17.7M +2.34M +15.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 17.7M +2.34M +15.2% Dec 31, 2021 10-K 2023-03-14
Q3 2021 17.7M +2.35M +15.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 15.4M +11.5K +0.08% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 15.4M -22.1M -59% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 15.4M +9.28M +152% Dec 31, 2020 10-K 2022-03-25
Q3 2020 15.4M -22M -58.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15.4M -22M -58.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 37.5M +147K +0.39% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 6.09M -31.2M -83.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 37.4M +504K +1.37% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 37.3M +9.75M +35.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 37.3M +9.76M +35.4% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 37.3M +9.8M +35.6% Dec 31, 2018 10-K 2020-03-05
Q3 2018 36.9M +9.38M +34.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 27.6M +130K +0.47% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 27.6M +208K +0.76% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 27.5M +157K +0.57% Dec 31, 2017 10-K 2019-03-14
Q3 2017 27.5M +155K +0.57% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 27.4M +177K +0.65% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 27.4M +81.8K +0.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 27.3M +90K +0.33% Dec 31, 2016 10-K 2018-03-09
Q3 2016 27.3M +95.7K +0.35% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 27.3M +154K +0.57% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 27.3M +413K +1.54% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 27.2M +4.36M +19.1% Dec 31, 2015 10-K 2017-03-10
Q3 2015 27.2M +4.53M +19.9% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 27.1M +4.41M +19.4% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 26.9M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 22.9M +22.1M +3037% Dec 31, 2014 10-K 2016-03-15
Q3 2014 22.7M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 22.7M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 729K Dec 31, 2013 10-K 2015-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.